Table 4 Sensitivity specificity, PPV, NPV, PLR, NLR, and concordance rate of microorganism detected by the MNCP-II-B.
MNCP-II-B | Sensitivity | Specificity | PPV | NPV | PLR | NLR | Concordance rate |
|---|---|---|---|---|---|---|---|
Meropenem | 93.02% | 84.85% | 94.12% | 82.35% | 6.14 | 0.08 | 90.76% |
Ceftazidime plus clavulanic acid | 92.22% | 86.21% | 95.40% | 78.13% | 6.69 | 0.09 | 90.76% |
Amikacin | 76.32% | 83.95% | 69.05% | 88.31% | 4.76 | 0.34 | 81.51% |
Oxacillin | 83.33% | 90.32% | 83.33% | 90.32% | 8.61 | 0.18 | 87.76% |
Vancomycin | 71.43% | 88.57% | 71.43% | 88.57% | 6.25 | 0.32 | 83.67% |
Erythromycin | 70.00% | 84.21% | 87.50% | 64.00% | 4.43 | 0.36 | 75.51% |
